Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Lic. from: BI Int'l GmbH, Made in Italy, NDC 0597-0030-01
Published October 18, 2017 · Recall initiated: September 22, 2017
Summary
FDA records drug Class III recall D-0007-2018, published October 18, 2017 and initiated September 22, 2017. Recalling firm: Boehringer Ingelheim Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 128 bottles; Lot: Lot 754037. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Distributor
- CO, OH
- Lot
- Lot 754037
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASynjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60July 8, 2026
- FDAJARDIANCE (Empagliflozin), 25 mg Tablets, packaged in a) 30-count (NDC0597-0153-30) and b) 90-count (NDCMarch 29, 2023
- FDAMicardis Tablets, (telmisartan Tablets) 80 mg, 30 ct. per folding cartons, Rx only, NDC 0597-0041-37),June 9, 2021
- FDACatapres (clonidine hydrochloride, USP) 0.2 mg, tablet, 100-count bottle, Rx only, Dist. by: BoehringerNovember 4, 2020
- FDAGlutamine, Arginine and Carnitine, 10/100/200mg/mL, 30 mL (Multi Dose Vial), Rx Only, For Injection, UnitedOctober 18, 2017
- FDASECURE(R) 100mL EMPTY VINYL CONTAINER With 2 Ports - (5 Boxes of 40), REF 58719, STERILE R,October 11, 2017
Questions about this recall
Was Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Lic. from: BI Int'l GmbH, Made in Italy, NDC 0597-0030-01 recalled?
Yes. FDA published recall D-0007-2018 on October 18, 2017. Reported hazard: Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.
What should I do if I have this product?
Voluntary: Firm initiated · Letter